A detailed history of Bruce G. Allen Investments, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 1,073 shares of AZN stock, worth $71,493. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,073
Previous 860 24.77%
Holding current value
$71,493
Previous $67.1 Million 24.64%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$76.67 - $87.62 $16,330 - $18,663
213 Added 24.77%
1,073 $83.6 Million
Q2 2024

Jul 12, 2024

BUY
$66.81 - $80.83 $9,219 - $11,154
138 Added 19.11%
860 $67.1 Million
Q1 2024

Apr 10, 2024

BUY
$61.03 - $69.57 $610 - $695
10 Added 1.4%
722 $48.9 Million
Q4 2023

Jan 10, 2024

BUY
$61.89 - $69.28 $44,065 - $49,327
712 New
712 $48 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.